title: The challenge of conducting comparative effectiveness research in cancer: the impact of a fragmented U.S. health-care system.
abstract: Comparative effectiveness research (CER) can make important contributions to the transformation of US health care by filling gaps left by tightly controlled clinical trials. However, without comprehensive and comparable data that reflect the diversity of the US health-care system, CER's value will be diminished. We document the limits of observational CER by examining the age at diagnosis, disease stage, and select measures of health-care use among individuals diagnosed with incident cancer aged 65 or older from four large health maintenance organizations (HMOs) relative to seniors identified through the linked Surveillance, Epidemiology, and End Results (SEER)-Medicare data for the period 1999-2007. Aged individuals in the HMOs were younger, diagnosed at earlier stages, and more likely to receive care in inpatient settings than individuals in the linked SEER-Medicare data. These differences highlight the need for comprehensive and comparable datasets that reflect the diversity of US health care to support CER that can inform health-care reform in the United States.
authors: Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA. fishman.p@ghc.org
authors: Paul A
authors: PA
authors: Fishman
authors: Mark C
authors: MC
authors: Hornbrook
authors: Debra P
authors: DP
authors: Ritzwoller
authors: Maureen C
authors: MC
authors: O'Keeffe-Rosetti
authors: Jennifer Elston
authors: JE
authors: Lafata
authors: Ramzi G
authors: RG
authors: Salloum
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D057186:Comparative Effectiveness Research; D003695:Delivery of Health Care; D005260:Female; D006279:Health Maintenance Organizations / Q000191:economics / Q000458:organization & administration; D006801:Humans; D008297:Male; D006278:Medicare / Q000191:economics; D009369:Neoplasms / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology; D018426:SEER Program; D014481:United States / Q000453:epidemiology
references: Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):769-73
references: 16614122
references: J Natl Cancer Inst. 2011 Jan 19;103(2):117-28
references: 21228314
references: JAMA. 2005 Jan 19;293(3):293-4
references: 15657315
references: Arch Intern Med. 2007 Nov 26;167(21):2289-95
references: 18039986
references: JAMA. 2003 Mar 12;289(10):1278-87
references: 12633190
references: JAMA. 2004 Mar 10;291(10):1238-45
references: 15010446
references: QJM. 2011 Dec;104(12):1075-81
references: 21835781
references: Am J Public Health. 1994 Oct;84(10):1598-604
references: 7943477
references: Palliat Support Care. 2011 Mar;9(1):3-13
references: 21352613
references: J Natl Cancer Inst. 1998 Jul 1;90(13):986-90
references: 9665146
references: Arch Intern Med. 2011 Dec 12;171(22):2043-6
references: 22025097
references: BMJ. 2006 Mar 25;332(7543):727
references: 16565136
references: J Womens Health (Larchmt). 2010 Sep;19(9):1619-24
references: 20815756
references: Health Aff (Millwood). 2010 Oct;29(10):1818-25
references: 20921481
references: Nat Clin Pract Oncol. 2007 Nov;4(11):643-56
references: 17965642
references: Ann Epidemiol. 1996 Sep;6(5):413-9
references: 8915472